64×10ml Swing Buckets Rotor

• Format: 96-well microtiter plate (12 test strips of 8 wells)
• Standards: 0 | 0.1 | 0.25 | 0.5 |1.0 | 2.6 ppb
• Incubation Time: 75 Minutes

Description

Brevetoxin: Competitive ELISA for the quantitative analysis of Brevetoxin in samples

Format: 96-well microtiter plate (12 test strips of 8 wells)

Standards: 0 ppb | 0.1  ppb | 0.25 ppb | 0.5 ppb | 1 ppb | 2.5 ppb

Incubation Time: 75 Minutes

Brevetoxins (PbTx) are a class of cyclic polyether compounds produced by certain algae such as Karenia brevis. K. brevis can produce Brevetoxins in large quantities during an algae bloom which then pose a major health threat and are important to monitor and mitigate. Brevetoxins are the causative agent of Neurotoxic Shellfish Poisoning (NSP).

FDA and EPA safety levels in regulations and guidance – 0.8 mg/kg for clams, mussels, oysters, and whole and roe-on scallops, fresh, frozen, or canned. – National Shellfish Sanitation Program Guide for the Control of Molluscan Shellfish.

Format: 96-well microtiter plate (12 test strips of 8 wells)
Standards: 0 | 0.1 | 0.25 | 0.5 |1.0 | 2.6 ppb
Incubation Time: 75 Minutes

DBCO-PEG4-PC represents a photocleavable, PEG linker consisting of a DBCO group that can be used for copper-free Click Chemistry reactions. This structure allows for efficient photorelease of linked molecules, typically achieving over 90% cleavage in 5-25 minutes using a near-UV lamp. The PEG4 spacer increases the hydrophilicity of the compound.

DBCO-PEG4-PC represents a photocleavable, PEG linker consisting of a DBCO group that can be used for copper-free Click Chemistry reactions. This structure allows for efficient photorelease of linked molecules, typically achieving over 90% cleavage in 5-25 minutes using a near-UV lamp. The PEG4 spacer increases the hydrophilicity of the compound.

Description 

The RNAok™ RNase Inhibitor is a recombinant mammalian RNase inhibitor which possesses very high affinity for eukaryotic pancreatic-type ribonuclease. The RNAok™ RNase Inhibitor forms a 1:1 complex with pancreatic RNase A by noncovalent binding, presenting a noncompetitive inhibitory activity on these pancreatic enzymes. RNAok™ RNase Inhibitor is active against RNase A, RNase B, RNase C but not RNAse H, RNase I, RNase T1, RNase T2, and S1 nuclease. RNAok™ RNase Inhibitor is compatible with RT-PCR enzymes such as AMV, M-MLV and ExcelRT™ Reverse Transcriptase or Taq DNA polymerase.

Application

•  cDNA Synthesis
• in vitro translation
• in vitro transcription
• One-step RT-PCR
• Separation and identification of specific ribonuclease activities

Storage Buffer

40 mM HEPES-KOH (pH 7.5), 100 mM KCl, 8 mM DTT,   0.1 mM EDTA, stabilizer and 50% (v/v) glycerol

Storage

-20°C for 24 months 

The RNAok™ RNase Inhibitor is a recombinant mammalian RNase inhibitor which possesses very high affinity for eukaryotic pancreatic-type ribonuclease. The RNAok™ RNase Inhibitor forms a 1:1 complex with pancreatic RNase A by noncovalent binding, presenting a noncompetitive inhibitory activity on these pancreatic enzymes. RNAok™ RNase Inhibitor is active against RNase A, RNase B, RNase C but not RNAse H, RNase I, RNase T1, RNase T2, and S1 nuclease. RNAok™ RNase Inhibitor is compatible with RT-PCR enzymes such as AMV, M-MLV and ExcelRT™ Reverse Transcriptase or Taq DNA polymerase.